lobbying_activities: 3234284

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3234284	b3b24423-a540-4314-acea-fa693e033887	Q3	LMH STRATEGIC SOLUTIONS	401108183	GLAXOSMITHKLINE LLC	2024	third_quarter	PHA	General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2024-10-09T14:55:58-04:00